ArticleThe Lancet. Infectious diseases2020
M1
Article in The Lancet. Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- Tracing the recent evolution of Group AEmerging microbes & infections · 2026Review
- Whole Genome Sequencing Analysis of Group AJournal of Korean medical science · 2026Article
- Emergence of distinct Streptococcus pyogenes emm1 and emm12 lineages in China.Nature microbiology · 2026Article
- Article
- Acquisition of toxin-encoding lysogenic bacteriophage elements enhances the virulence of pandemicInfection and immunity · 2026Article
- Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and Wales.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Article
- Core-genome Single-nucleotide Polymorphism Analysis ofAnnals of laboratory medicine · 2025Article
- A Rapid Molecular Detection Tool for Toxigenic M1UK Streptococcus pyogenes.The Journal of infectious diseases · 2025Article
- Characterization of a novelmBio · 2025Article
- The burden of group AiScience · 2025Review
- Article
- The intricate pathogenicity of Group AVirulence · 2024Review
- Divergent effects ofJournal of clinical microbiology · 2024Article
- Local Genomic Surveillance of InvasiveInternational journal of molecular sciences · 2024Article
- Rapid expansion and international spread of M1Nature communications · 2024Article
- Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1Infection · 2024Article
- Increase in invasiveEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
- Mediastinitis secondary to invasive infection by group A Streptococcus in Spain.European journal of pediatrics · 2024Review
- Expansion of Invasive Group A Streptococcus M1Emerging infectious diseases · 2023Article
- Group A Streptococcus Meningitis in Adults, Denmark.Emerging infectious diseases · 2023Article
Corrections and comments
- Comment on
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.